Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.70 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.70 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.70 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.70 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.70 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.70 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.70 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.70 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.70 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.70 |
| ▸ | CDC25A | P30304 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL135273 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL28008854 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL7126727 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL14676689 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL4739596 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL19866272 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| SCHEMBL28898907 | 1.00 | CYP2D6 (0.71) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Water SCHEMBL27578106 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Methane SCHEMBL27524872 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 | |
| Ethane SCHEMBL8333555 | 0.99 | CYP2D6 (0.70) | CYP2D6CYP2C19EPHA2AKR1B10AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4577196-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | Popvax Private Limited (IN) | 2025-07-02 | — | — | EP | claimed |
| WO-2025052180-A2 | LIPIDS AND LIPID NANOPARTICLES | Axelyf ehf. (IS) | 2025-03-13 | — | — | WO | claimed |
| CN-114206360-B | Nanoparticle containing cell membrane and use thereof | 阿瑞萨生物科技有限责任公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024044178-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | POPVAX PRIVATE LIMITED (IN) | 2024-02-29 | — | — | WO | claimed |
| US-20230203091-A1 | GLYCOCONJUGATION PROCESS | PFIZER (US) | 2023-06-29 | — | — | US | claimed |
| EP-4106828-A1 | POLYMER-ENCAPSULATED DRUG PARTICLES | GIE Medical, Inc. (US) | 2022-12-28 | — | — | EP | claimed |
| CN-115461096-A | Polymer encapsulated drug particles | 吉益医疗公司 | 2022-12-09 | — | — | CN | claimed |
| CN-114206360-A | Cell membrane-containing nanoparticles and uses thereof | 阿瑞萨生物科技有限责任公司 | 2022-03-18 | — | — | CN | claimed |
| CN-113968890-A | Preparation method of plant source 7-ketolithocholic acid isomer impurity | 湖南科瑞生物制药股份有限公司 | 2022-01-25 | — | — | CN | claimed |
| US-20120136581-A1 | Method of Diagnosing Asphyxia | BIOCRATES LIFE SCIENCES AG (AT) | 2012-05-31 | — | — | US | claimed |
| EP-2427773-A1 | METHOD OF DIAGNOSING ASPHYXIA | Keller, Matthias (DE) | 2012-03-14 | — | — | EP | claimed |
| WO-2010128054-A1 | METHOD OF DIAGNOSING ASPHYXIA | BIOCRATES LIFE SCIENCES AG (AT) | 2010-11-11 | — | — | WO | claimed |
| EP-2249161-A1 | Method of diagnosing asphyxia | BIOCRATES Life Sciences AG (AT) | 2010-11-10 | — | — | EP | claimed |
| CN-122080999-A | Preparation method of soybean oil compound blend oil | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026102108-A1 | DNA PRODUCTION METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-3755675-B1 | ACCELERATED PEROXIDE-CURED RESIN COMPOSITIONS HAVING EXTENDED OPEN TIMES | ARKEMA INC (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-1998001759-A1 | A METHOD OF ASSESSING RISK FOR CARDIOVASCULAR DISEASE AND OTHER DISORDERS AND PHYTOSTEROL-BASED COMPOSITIONS USEFUL IN PREVENTING AND TREATING CARDIOVASCULAR DISEASE AND OTHER DISORDERS | FORBES MEDI-TECH INC. (CA) | 1998-01-15 | — | — | WO | disclosed |
| US-5480805-A | Composition for modulating sterols in yeast | AMOCO CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| US-5460949-A | Increasing gene expression encoding polypeptide having HMG-CoA activity in mutant yeast; culturing | AMOCO CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| EP-0486290-A2 | A method and composition for increasing the accumulation of squalene and specific sterols in yeast | AMOCO CORPORATION (US) | 1992-05-20 | — | — | EP | disclosed |